Stopped: Submission process abandoned. No patient enrolled.
Postoperative management of oral anticoagulation is a frequent preoccupation in cardiac surgery, concerning about half of patients. Vitamin K antagonists are often recommended but their management is not easy due to the high dose-response patient variability. Pharmacologically more stable, direct oral anticoagulants have similar efficiency in preventing thromboembolic complications while they decrease the risk of bleeding in certain patient populations. The objective of study is to assess the safety and efficacy of direct oral anticoagulants in the postoperative period of cardiac surgical procedures.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Hemorrhagic events with anticoagulant treatment
Timeframe: Evaluation at month 3 after hospital discharge for all the postoperative period
Ischemic events with anticoagulant treatment
Timeframe: Evaluation at month 3 after hospital discharge for all the postoperative period
Death with anticoagulant treatment
Timeframe: Evaluation at month 3 after hospital discharge for all the postoperative period
Quality of life with anticoagulant treatment
Timeframe: Evaluation at month 3 after hospital discharge for the last month
Statisfaction of the anticoagulant treatment
Timeframe: Evaluation at month 3 after hospital discharge for the last month